Imaging insights into basal ganglia function, Parkinson's disease, and dystonia.
Ontology highlight
ABSTRACT: Recent advances in structural and functional imaging have greatly improved our ability to assess normal functions of the basal ganglia, diagnose parkinsonian syndromes, understand the pathophysiology of parkinsonism and other movement disorders, and detect and monitor disease progression. Radionuclide imaging is the best way to detect and monitor dopamine deficiency, and will probably continue to be the best biomarker for assessment of the effects of disease-modifying therapies. However, advances in magnetic resonance enable the separation of patients with Parkinson's disease from healthy controls, and show great promise for differentiation between Parkinson's disease and other akinetic-rigid syndromes. Radionuclide imaging is useful to show the dopaminergic basis for both motor and behavi
SUBMITTER: Stoessl AJ
PROVIDER: S-EPMC4454525 | biostudies-literature | 2014 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA